NEW YORK (GenomeWeb News) - The University of North Carolina at Chapel Hill has licensed InforSense's workflow-based analytics platform for use in pharmacogenomics research projects, the company said yesterday.
The Institute of Pharmacogenomics and Individualized Therapy at UNC-CH will use the GenSense software in its efforts to develop "precise, effective treatment options for individual patients suffering from a wide range of conditions," InforSense said.
The institute is focused on identifying genetic variants that may predispose patients to severe side effects or poor response to certain drugs.
The company said the GenSense software will enable IPIT to "leverage expression data, DNA and micoarray analysis, electronic medical records, and various relational databases to drive its interdisciplinary research initiatives."
Financial terms of the agreement were not released.